Q8, Q9, & Q10 Questions and Answers -- Appendix: Q&As from Training Sessions (Q8, Q9, & Q10 Points to Consider) - FDA Guidance Document | Global Key Solutions

Q8, Q9, & Q10 Questions and Answers -- Appendix: Q&As from Training Sessions (Q8, Q9, & Q10 Points to Consider)

Detailed guidance document from FDA and regulatory agencies.

Document Details

Document Type

Guidance Document

Issue Date

August 13, 2012

Last Updated

April 15, 2020

Office

Center for Drug Evaluation and Research

Document ID

74f08aab-1b94-4f9f-8da0-2725af03d078

Related Documents

S6(R1) Addendum: Preclinical Safety Evaluation of Biotechnology: Guidance for Industry

Guidance DocumentDecember 17, 2009Center for Drug Evaluation and Research

View Details →

Q11 Development and Manufacture of Drug Substances

Guidance DocumentNovember 20, 2012Center for Drug Evaluation and Research

View Details →

Q8, Q9, and Q10 Questions and Answers

Guidance DocumentNovember 17, 2011Center for Drug Evaluation and Research

View Details →

Quick Actions

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox